KAS-1155

N/A

Report date: 2025/04/28 17:47:35
NME

Base Information

Drug NameKAS-1155
Drug Alias NameKAS-1155
ClassificationSmall molecules
Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 inhibitors
TargetsEukaryotic translation initiation factor 2-alpha kinase 4
Therapy Area/IndicationsRhabdomyosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYonsei University
China Registration ClassN/A

Develop Information

Active CompaniesYonsei University
Inactive CompaniesN/A
Active IndicationsRhabdomyosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A